Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I studyConstantijne H Mom, Jaap Verweij, Corina N A M Oldenhuis, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2010
Effects of methimazole on the elimination of irinotecanJessica M van der Bol, Theo J Visser, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecanJessica M van der Bol, Ron H J Mathijssen, Geert-Jan M Creemers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapyAnne-Joy M de Graan, Walter J Loos, Lena E Friberg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2011
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction studyJessica M van der Bol, Walter J Loos, Floris A de Jong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropeniaJessica M van der Bol, Ron H J Mathijssen, Walter J Loos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulationMaja J A de Jonge, Marije Slingerland, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2012
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patientsKarel Eechoute, Martin N Fransson, An K Reyners, et al.
Pageof 6